Diabetic Ketoacidosis

• Absolute or Relative Insulin Deficiency and Loss of Metabolic Brake: In type 1 diabetes, autoimmune destruction of pancreatic β cells results in minimal or absent endogenous insulin secretion. In type 2 diabetes or stress-induced hyperglycemic states, acute illness or medications can precipitate relative insulin deficiency despite residual β-cell function. Insulin normally suppresses hepatic glucose production, inhibits adipose lipolysis, and promotes glucose utilization in muscle and adipose tissue. Without adequate insulin action, all three metabolic processes become dysregulated simultaneously. The loss of insulin's inhibitory effect on lipolysis becomes the primary pathogenic driver of ketone overproduction—more critical than the direct stimulation of ketogenesis.

• Counter-Regulatory Hormone Surge and Metabolic Amplification: In response to perceived hypoglycemia (despite actual hyperglycemia due to glucose sensing defects) and systemic stress, the sympathetic nervous system and hypothalamic-pituitary-adrenal axis release epinephrine, norepinephrine, glucagon, cortisol, and growth hormone. Glucagon, the most important counter-regulatory hormone in DKA, acts via G-protein coupled receptors on hepatocytes to increase adenylyl cyclase activity, raising intracellular cAMP and activating protein kinase A (PKA). PKA phosphorylates key glycogen-metabolizing enzymes (glycogen synthase, phosphorylase kinase) and glucose-6-phosphatase regulatory proteins, simultaneously promoting glycogenolysis and gluconeogenesis. Epinephrine amplifies this effect in adipose tissue by activating hormone-sensitive lipase (HSL), which is phosphorylated by PKA, triggering massive hydrolysis of triglycerides into free fatty acids (FFAs) and glycerol. Cortisol enhances gluconeogenesis and lipolysis by inducing PEPCK and other gluconeogenic enzymes; growth hormone antagonizes insulin action. These hormones act synergistically—glucagon primarily drives hepatic glucose overproduction, while catecholamines and cortisol maximize lipolysis. The net result is hepatic glucose output of 500–800 mg/kg/day (normal: 100–150 mg/kg/day).

• Uncontrolled Hepatic Ketogenesis and Ketone Body Accumulation: The surge in FFAs delivered to the liver exceeds the capacity of mitochondria to fully oxidize them via β-oxidation to acetyl-CoA. Under normal fed conditions, insulin inhibits malonyl-CoA formation (via inhibition of acetyl-CoA carboxylase), allowing fatty acyl-CoA to enter mitochondria through the carnitine palmitoyltransferase (CPT-I) shuttle for complete oxidation. In DKA, the FFA influx and loss of insulin inhibition cause unopposed ketogenesis. Hepatic mitochondria convert excess acetyl-CoA into ketone bodies via the following pathway: (1) two acetyl-CoA molecules condense via thiophorase to form acetoacetyl-CoA; (2) HMG-CoA synthase condenses acetoacetyl-CoA with another acetyl-CoA to form HMG-CoA; (3) HMG-CoA lyase cleaves HMG-CoA into acetoacetate and acetyl-CoA; (4) acetoacetate is reduced to β-hydroxybutyrate by β-hydroxybutyrate dehydrogenase, with the ratio of β-hydroxybutyrate to acetoacetate typically 3:1 (but can reach 10:1 in severe DKA due to increased NADH/NAD+ ratio from metabolic stress). Only hepatocytes and, to a minor extent, the renal cortex produce ketone bodies; extrahepatic tissues cannot synthesize them. Ketone bodies accumulate in blood to concentrations of 5–25 mEq/L (normal: <1 mEq/L), with β-hydroxybutyrate comprising 70–80% of total ketones. Ketones are organic acids; their dissociation produces H+ ions, causing profound high anion gap metabolic acidosis (anion gap typically 12–20 mEq/L; normal <12). The buffering capacity of extracellular and intracellular buffers (bicarbonate, phosphate, hemoglobin) becomes overwhelmed, pH drops below 7.30 (often 6.9–7.1 in severe DKA), and respiratory compensation via hyperventilation becomes the dominant mechanism maintaining pH.

• Osmotic Hyperglycemia and Hyperosmolality Driving Transcellular Fluid Shifts: Severe hyperglycemia (typically 300–800 mg/dL, often >1000 mg/dL) exceeds the renal glucose reabsorption threshold (~180 mg/dL). Filtered glucose is not reabsorbed and acts as an osmotic diuretic in the proximal tubule, obligating water reabsorption but not sodium or potassium. This osmotic diuresis results in urinary losses of 5–10 L of fluid and 500–1000 mEq of sodium and potassium over 24–48 hours. Severe hyperglycemia raises plasma osmolality (normal: 280–300 mOsm/kg) to 320–350+ mOsm/kg, creating an osmotic gradient between extracellular and intracellular compartments. Water moves out of cells (intracellular dehydration) into the extracellular space, causing pseudohyponatremia—measured serum sodium is paradoxically low (130–135 mEq/L) despite hypertonicity. The corrected sodium is calculated as: corrected [Na+] = measured [Na+] + 1.6 × ([glucose in mg/dL - 100]/100). This transcellular water shift explains why patients with DKA are often significantly dehydrated (deficit of 6–10 L) yet may not appear clinically dry.

• Renal Bicarbonate Loss and Worsening Acidosis: In normal physiology, the kidney reabsorbs filtered bicarbonate via proximal tubule H+ secretion coupled to Na+/H+ exchange (mediated by NHE3). In DKA, severe hyperglycemia obligates osmotic diuresis, reducing proximal tubule transit time and limiting bicarbonate reabsorption. Additionally, ketonuria (both acetoacetate and β-hydroxybutyrate are filtered at the glomerulus, exceeding tubular reabsorption capacity) increases urinary anion excretion, which must be coupled with cation loss (Na+, K+) to maintain electroneutrality. This urine is not simply "wasting" ketones—these anions carry electrolytes away, compounding electrolyte depletion. The net effect is that the kidneys cannot compensate for ongoing hepatic ketone overproduction; urinary ketone excretion reaches 50–100 mEq/L. The anion gap remains persistently elevated because filtered ketones are eliminated but acid-base balance deteriorates due to bicarbonate depletion.

• Respiratory Compensation and Kussmaul Respiration: The respiratory center becomes exquisitely sensitive to acidosis at pH <7.2. Peripheral chemoreceptors respond to elevated H+ and stimulate the dorsal and ventral respiratory groups in the medulla. Pulmonary ventilation increases proportionally to the logarithm of [H+], attempting to eliminate CO₂ (volatile acid) and raise pH via the Henderson-Hasselbalch equation. Predicted respiratory compensation (using Winter's formula) would lower pCO₂ by 1.2–1.3 mmHg for every 1 mEq/L drop in HCO₃⁻ below 24. In DKA, pCO₂ often falls to 15–25 mmHg or lower, achieving maximal respiratory compensation (pCO₂ cannot fall below ~10 mmHg due to mechanical limits of ventilation). The resulting breathing pattern—rapid, deep, and stereotyped—is Kussmaul respiration, characterized by a distinctive gasping quality and audible fruity odor on the breath (acetone from spontaneous decarboxylation of acetoacetate by ambient temperature).

• Inflammatory Cascade and Microvascular Dysfunction: Severe acidosis, hyperglycemia, and oxidative stress activate multiple inflammatory pathways. TNF-α, IL-1, IL-6, and IL-8 are elevated. Cytokine and chemokine release recruits neutrophils, which become dysfunctional in acidosis (impaired chemotaxis, phagocytosis, respiratory burst at pH <7.2). Endothelial dysfunction results from increased expression of cell adhesion molecules and loss of nitric oxide-mediated vasodilation. These inflammatory changes predispose to acute lung injury, adult respiratory distress syndrome (ARDS), and thrombotic complications. Cerebral edema, the most feared neurological complication, likely results from shifts in cerebral osmolality (the brain's osmolytes—sorbitol, taurine, myo-inositol—accumulate during hyperglycemia and acidosis), water entry via aquaporin channels, and inflammatory cytokine-mediated blood-brain barrier breakdown.

• Type 1 Diabetes Mellitus (Most Common, ~90% of DKA Cases): Autoimmune destruction of pancreatic β cells results in absolute insulin deficiency. DKA typically manifests at diabetes onset (new-onset DKA is a presenting feature in 15–30% of type 1 diabetes diagnoses) or during periods of acute illness, stress, or medication non-compliance. Patients with "brittle" or unstable diabetes characterized by recurrent DKA episodes and rapid glycemic fluctuations are at particular risk. Eating disorders (especially disordered insulin omission) increase risk significantly.

• Infection (Leading Precipitant in Established Type 1 Diabetes): Bacterial, viral, and fungal infections account for 30–50% of DKA episodes in known diabetics. Pneumonia, urinary tract infection, and meningitis are common culprits. Infections trigger inflammatory cytokine release, which antagonizes insulin action and increases counter-regulatory hormone secretion. Even asymptomatic infections (e.g., occult UTI in elderly patients) can precipitate DKA. Atypical infectious agents—mucormycosis, candidiasis—are particularly dangerous in DKA because they thrive in hyperglycemic, acidotic conditions and may be rapidly progressive. Sepsis-induced DKA has higher mortality.

• Medication Non-Compliance and Insulin Omission: Intentional or unintentional cessation of insulin therapy precipitates DKA within 24–48 hours in type 1 diabetics. Patients with concurrent psychiatric illness, depression, or eating disorders are at elevated risk. This is the most preventable cause and warrants screening for psychosocial barriers to adherence.

• Acute Illness and Physiological Stress: Myocardial infarction, stroke, sepsis, trauma, surgery, and acute pancreatitis trigger massive counter-regulatory hormone release. Even mild infections activate the stress response. Patients with type 2 diabetes can develop DKA during severe acute illness, particularly if they are on insulin therapy. SGLT2 inhibitors (gliflozin class) have been associated with euglycemic DKA in both type 1 and type 2 diabetes—a particularly insidious presentation where DKA occurs at near-normal glucose levels (150–250 mg/dL), delaying diagnosis. SGLT2 inhibitors increase renal glucose excretion and may directly stimulate glucagon secretion or reduce insulin secretion, creating a state of relative insulin deficiency with ongoing ketone overproduction despite near-normal glycemia.

• Intracranial Events and Hypothalamic-Pituitary Dysfunction: Stroke, traumatic brain injury, subdural hematoma, and subarachnoid hemorrhage can directly precipitate DKA via hypothalamic-pituitary activation and catecholamine surge. This phenomenon is called "stress hyperglycemia" or "stress ketoacidosis." Rarely, central diabetes insipidus or hypopituitarism following pituitary apoplexy can lead to DKA through loss of growth hormone's anti-insulin effects (paradoxically, growth hormone absence can allow insulin to work better, but acutely, the stress of the pituitary event precipitates DKA).

• Substance Abuse and Intoxication: Alcohol abuse, cocaine use, and amphetamine abuse impair nutritional intake and increase stress hormone release. Alcoholic ketoacidosis (AKA) is a related metabolic emergency characterized by ketosis without significant hyperglycemia; distinguishing AKA from DKA is crucial because AKA is treated with dextrose and supportive care, not insulin.

• Medications Associated with DKA:
• GLP-1 receptor agonists: Rare cases of DKA reported, possibly via altered insulin secretion or direct pancreatic effects
• Corticosteroids: Suppress insulin secretion and promote gluconeogenesis; DKA risk increases if given acutely at high doses
• Diuretics: Hypokalemia and volume depletion trigger counter-regulatory hormone release
• SGLT2 inhibitors: As discussed, euglycemic DKA risk

• Type 2 Diabetes and Euglycemic DKA: While classically associated with type 1 diabetes, type 2 diabetics—especially those on insulin, GLP-1 agonists, or SGLT2 inhibitors—can develop DKA. The emergence of euglycemic DKA (glucose 150–250 mg/dL with pH <7.35 and anion gap >12) has shifted clinical suspicion; patients may not appear hyperglycemic, and non-glucose parameters must drive diagnosis.

• Age and Demographic Factors: Peak incidence occurs in children and young adults with type 1 diabetes, though DKA can occur at any age. Elderly patients with long-standing type 1 diabetes may present atypically with subtle symptoms, delaying diagnosis and increasing mortality. Pregnant women are at increased risk due to pregnancy-associated insulin resistance and altered metabolic rates; DKA can occur at lower glucose levels in pregnancy.

• Polyuria and Polydipsia (Early Symptoms, Hours to Days Prior): Osmotic hyperglycemia exceeds renal glucose threshold, obligating water reabsorption without sodium reabsorption (osmotic diuresis). Patients report frequent urination, often waking at night (nocturia), with massive volume losses (5–10 L/day). Dehydration activates the renin-angiotensin-aldosterone system and thirst centers; patients drink excessively but cannot keep pace with urinary losses. These symptoms may be mistaken for infection (UTI) or thyroid disease (diabetes insipidus), delaying DKA recognition.

• Nausea, Vomiting, and Abdominal Pain (Cardinal Acute Symptoms): Metabolic acidosis (pH <7.3) triggers chemoreceptor areas in the medulla and directly irritates the gastric mucosa. Vomiting is prominent and often described as projectile; it worsens dehydration and electrolyte loss. Abdominal pain is a frequent presenting complaint, often located in the epigastrium or periumbilical region, and can be severe. The pain is visceral, caused by gastric distension, acidosis-induced gut dysmotility, and possible associated acute pancreatitis (30–50% of DKA patients have elevated amylase/lipase, though clinically significant pancreatitis is rare). Patients may be misdiagnosed with acute abdomen

Initial bedside testing

• Point-of-care glucose and venous blood gas: a VBG is adequate — venous and arterial pH correlate closely, so arterial puncture is not required. Look for low pH with a low pCO₂ (respiratory compensation, Kussmaul respiration).
• Basic metabolic panel with calculated anion gap: AG = Na⁺ − (Cl⁻ + HCO₃⁻). A high anion gap with low bicarbonate is the acid–base signature. Always correct sodium for hyperglycemia and interpret potassium knowing total-body stores are depleted even when serum K⁺ is normal or high.
• ECG: fastest surrogate for dangerous potassium shifts (peaked T waves, or flattening/U waves with hypokalemia).

Confirmatory test

• Serum (or capillary) β-hydroxybutyrate: the preferred confirmatory ketone assay per the ADA. Urine nitroprusside detects only acetoacetate and acetone, not β-hydroxybutyrate — the dominant ketone in DKA — so urine dipstick can under-call severity at presentation and paradoxically appear to worsen during recovery as β-hydroxybutyrate is oxidized back to acetoacetate.

Diagnostic triad (ADA/EASD hyperglycemic crises consensus)

• Hyperglycemia: glucose above roughly 200 mg/dL, or a known diabetes diagnosis — the threshold was lowered from the older 250 mg/dL figure specifically to capture euglycemic DKA (SGLT2 inhibitors, pregnancy, starvation, alcohol, hepatic glycogen depletion).
• Ketosis: elevated β-hydroxybutyrate or moderate-to-large ketonuria.
• Metabolic acidosis: pH below 7.3 and/or bicarbonate below 18 mEq/L, with an elevated anion gap.

Severity and mimics

• Severity grading uses pH, bicarbonate, and mental status: milder disease has near-normal sensorium, while severe DKA has markedly acidemic pH, very low bicarbonate, and stupor or coma.
• Effective osmolality = 2×Na⁺ + glucose/18; marked hyperosmolality with minimal ketoacidosis points to HHS, and overlap syndromes occur.
• Search for the precipitant: CBC (leukocytosis is expected from stress, but a left shift or fever suggests infection), urinalysis and cultures, chest radiograph, troponin/ECG, lipase, and pregnancy testing.

1. Volume resuscitation (first action)

• Isotonic crystalloid: 0.9% saline or a balanced crystalloid (lactated Ringer's, Plasma-Lyte) given rapidly. Balanced solutions are increasingly favored because large-volume saline produces hyperchloremic non-gap acidosis that delays apparent resolution. Fluid alone lowers glucose and counter-regulatory hormone drive before any insulin is given.
• Subsequent fluids are guided by corrected sodium and hemodynamics; switch to a hypotonic solution if corrected sodium is normal or high.

2. Potassium before insulin

• Potassium chloride: insulin drives K⁺ intracellularly and can precipitate fatal hypokalemia. If serum K⁺ is below roughly 3.3 mEq/L, hold insulin and replete first. If K⁺ is in the normal range, add potassium to the fluids. Withhold potassium only if K⁺ is frankly elevated and urine output is confirmed.

3. Insulin

• Continuous IV regular insulin infusion at approximately 0.1 units/kg/hr is standard; a bolus is optional in adults and is not given in children.
• Subcutaneous rapid-acting insulin analog protocols (lispro/aspart) are an accepted alternative for uncomplicated mild-to-moderate DKA in monitored settings, but not for severe DKA, shock, or altered mental status.

4. Dextrose and de-escalation

• Add IV dextrose once glucose falls to roughly 200–250 mg/dL while continuing insulin — the insulin is treating ketoacidosis, not glucose. Stopping the drip when glucose normalizes is the classic error.
• Resolution is defined by closure of the anion gap/normalized β-hydroxybutyrate with bicarbonate and pH recovery, not by glucose alone.
• Transition to subcutaneous basal insulin with a 1–2 hour overlap before discontinuing the infusion to prevent rebound ketosis.

Adjuncts and what to avoid

• Bicarbonate: not recommended routinely; reserved for extreme acidemia (pH below ~6.9) and of unproven benefit — risks paradoxical CNS acidosis, hypokalemia, and cerebral edema.
• Phosphate: replace only for severe hypophosphatemia with cardiac, respiratory, or hemolytic compromise.
• Hold SGLT2 inhibitors and treat the precipitant (antibiotics, ACS care).

Treatment-related emergencies

• Hypokalemia (emergency): insulin plus bicarbonate and volume expansion shift and excrete K⁺ from an already depleted total-body pool. Signals: flattened T waves, U waves, ventricular ectopy, weakness, respiratory muscle failure. This is the most common iatrogenic cause of death in DKA.
• Cerebral edema (emergency, predominantly children): rapid fall in effective osmolality with brain accumulation of idiogenic osmolytes drives water into neurons; inflammatory blood–brain barrier injury contributes. Signals: headache, recurrent vomiting, incontinence, bradycardia with hypertension (Cushing reflex), and declining consciousness typically several hours into therapy. Treat with hypertonic saline or mannitol and reduce fluid rate; ISPAD emphasizes avoiding overly rapid osmolar correction.
• Hypoglycemia: from continuing insulin without adding dextrose once glucose approaches 200–250 mg/dL.
• Hyperchloremic non-anion-gap metabolic acidosis: large-volume 0.9% saline plus urinary loss of ketoanions (the bicarbonate precursors); the anion gap closes but bicarbonate stays low. Benign and self-limited — do not mistake it for persistent ketoacidosis.
• Fluid overload/pulmonary edema in patients with heart or kidney disease.

Disease-related complications

• Acute kidney injury: prerenal from osmotic diuresis and vomiting; may become ischemic ATN.
• Arterial and venous thrombosis (emergency): hyperosmolality, dehydration, and inflammatory endothelial dysfunction create a prothrombotic state — stroke, MI, DVT/PE.
• Rhinocerebral mucormycosis (emergency): Rhizopus thrives in acidemia because ketoacidosis frees iron from transferrin and impairs neutrophil function. Signals: black necrotic turbinate/palatal eschar, facial pain, cranial neuropathy, proptosis. Requires urgent surgical debridement plus amphotericin B.
• Aspiration pneumonitis: gastroparesis, vomiting, and obtundation; consider a nasogastric tube in the unresponsive patient.
• ARDS: falling colloid oncotic pressure with aggressive fluids plus cytokine-mediated capillary leak; signals are widening A–a gradient and hypoxemia.
• Hypophosphatemia: insulin drives phosphate intracellularly; severe depletion causes rhabdomyolysis, hemolysis, and diaphragmatic weakness.
• Pancreatitis: hypertriglyceridemia from unrestrained lipolysis.

• Fluids before insulin, potassium before insulin: the single best next step in a hypotensive DKA patient is isotonic crystalloid, not the insulin drip. If serum K⁺ is low, replete potassium first — giving insulin to a hypokalemic patient is a tested killer.
• Normal or high serum K⁺ hides profound total-body depletion: acidemia and insulin deficiency shift K⁺ extracellularly while osmotic diuresis dumps it in the urine. Expect potassium to fall once insulin starts.
• The urine nitroprusside trap: dipstick detects acetoacetate and acetone but not β-hydroxybutyrate, the predominant ketone. Urine ketones may appear to worsen during successful treatment as β-hydroxybutyrate is reoxidized to acetoacetate — do not escalate insulin for this. Follow the anion gap or serum β-hydroxybutyrate instead.
• Do not stop the insulin drip when glucose normalizes: add dextrose and keep insulin running until the gap closes, then overlap with subcutaneous basal insulin for 1–2 hours. Stopping the drip early causes rebound ketoacidosis.
• Euglycemic DKA: an SGLT2 inhibitor (or pregnancy, or starvation) with glucose near normal but pH low and ketones high. Boards use this to punish anchoring on glucose. Treat with insulin and dextrose simultaneously.
• Bicarbonate is almost never the answer: reserved for extreme acidemia, and even then unproven. The distractor is giving it for pH 7.1.
• A persistently low bicarbonate with a now-normal anion gap after resuscitation is hyperchloremic acidosis from saline, not treatment failure.
• Classic associations examiners love: fruity breath with Kussmaul respiration; abdominal pain and leukocytosis that resolve with treatment (do not rush to laparotomy); pseudohyponatremia that corrects with the 1.6 mEq/L per 100 mg/dL glucose formula; and a diabetic with black nasal eschar = rhinocerebral mucormycosis requiring urgent surgical debridement plus amphotericin B.
• In a child improving on therapy who develops headache, vomiting, bradycardia, and hypertension, the answer is cerebral edema — give hypertonic saline or mannitol and slow the fluids; do not order a CT before treating.